Syros Pharmaceuticals Stock Market Value
| SYRS Stock | USD 0.27 0.02 8.00% |
| Symbol | Syros |
Syros Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syros Pharmaceuticals. If investors know Syros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syros Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) | Revenue Per Share 0.01 | Quarterly Revenue Growth (0.03) | Return On Assets (0.60) | Return On Equity (7.77) |
The market value of Syros Pharmaceuticals is measured differently than its book value, which is the value of Syros that is recorded on the company's balance sheet. Investors also form their own opinion of Syros Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Syros Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syros Pharmaceuticals' market value can be influenced by many factors that don't directly affect Syros Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Syros Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Syros Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syros Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Syros Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Syros Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Syros Pharmaceuticals.
| 12/09/2022 |
| 11/28/2024 |
If you would invest 0.00 in Syros Pharmaceuticals on December 9, 2022 and sell it all today you would earn a total of 0.00 from holding Syros Pharmaceuticals or generate 0.0% return on investment in Syros Pharmaceuticals over 720 days. Syros Pharmaceuticals is related to or competes with Surrozen, Bolt Biotherapeutics, Larimar Therapeutics, Keros Therapeutics, Kezar Life, Ideaya Biosciences, and Syndax Pharmaceuticals. Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monoge... More
Syros Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Syros Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Syros Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 111.02 | |||
| Value At Risk | (15.48) | |||
| Potential Upside | 19.91 |
Syros Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Syros Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Syros Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Syros Pharmaceuticals historical prices to predict the future Syros Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.82) | |||
| Total Risk Alpha | (2.97) | |||
| Treynor Ratio | (0.77) |
Syros Pharmaceuticals Backtested Returns
Syros Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0393, which indicates the firm had a -0.0393% return per unit of risk over the last 3 months. Syros Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Syros Pharmaceuticals' Risk Adjusted Performance of (0.03), coefficient of variation of (2,062), and Variance of 206.68 to confirm the risk estimate we provide. The entity has a beta of 0.92, which indicates possible diversification benefits within a given portfolio. Syros Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Syros Pharmaceuticals is expected to follow. At this point, Syros Pharmaceuticals has a negative expected return of -0.58%. Please make sure to validate Syros Pharmaceuticals' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and relative strength index , to decide if Syros Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.36 |
Below average predictability
Syros Pharmaceuticals has below average predictability. Overlapping area represents the amount of predictability between Syros Pharmaceuticals time series from 9th of December 2022 to 4th of December 2023 and 4th of December 2023 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Syros Pharmaceuticals price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Syros Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 4.42 |
Syros Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Syros Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Syros Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Syros Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Syros Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Syros Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Syros Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Syros Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Syros Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Syros Pharmaceuticals Lagged Returns
When evaluating Syros Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Syros Pharmaceuticals stock have on its future price. Syros Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Syros Pharmaceuticals autocorrelation shows the relationship between Syros Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Syros Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Syros Stock Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.